スポンサーリンク
Department Of Breast Surgery Aichi Cancer Center Hospital | 論文
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Telomerase Activity Levels for Evaluating the Surgical Margin in Breast-Conserving Surgery
- Combination of Subareolar Blue Dye and Peritumoral RI for Sentinel Lymph Node Biopsy
- Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
- Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
- No Association of the 5' Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
- A Case of Metastatic Breast Cancer Achieving Complete Response by Combination Therapy with 5'-Deoxy-5-fluorouridine and Cyclophosphamide
- Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
- Readministration of Tamoxifen After Adjuvant Therapy for Recurrent Breast Cancer
- A Phase II Study of S-1 in Patients with Metastatic Breast Cancer : A Japanese Trial by the S-1 Cooperative Study Group, Breast Cancer Working Group
- Metachronous Primary Hyperparathyroidism Due to a Parathyroid Adenoma and a Subsequent Carcinoma : Report of a Case
- Estrogen Receptor α Mutation (A-to-G Transition at Nucleotide 908) Is Not Found in Different Types of Breast Lesions from Japanese Women)
- Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment
- Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
- A Case of Invasive Micropapillary Carcinoma of the Breast
- p33^ and Estrogen Receptor (ER) α
- A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment
- Survey on Pamphlet Use Explaining Breast Cancer Operations in Japan
- Mammographic and Ultrasonographic Findings of Invasive Lobular Carcinoma
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan